IX

On the numbers provided, ORIX looks like a classic cheap, recovering diversified financial. FY2012 net income of $1.05B caps a sharp two-year rebound (FY2010 $406M → FY2011 $809M → FY2012 $1.05B, +29.5% in the latest year), operating income jumped +71.3% to $1.52B, and operating cash flow surged +58.7% to $4.05B. Diluted EPS of $8.16 against a $40.15 price is a 4.9x P/E, which on its face is a deep-value multiple for a business compounding earnings at ~28%. The balance sheet is funding-heavy but not obviously stressed for a credit institution: $17.0B equity, $9.57B cash, retained earnings building (+7.9%), debt declining (long-term debt -4.7%, short-term -3.2%), and total assets flat — a deleveraging, self-funding posture rather than an aggressive one.

The quality, however, is only middling. Return on equity is just 6.2% and net margin 8.9% — modest for a lender carrying 4.93x liabilities-to-equity, meaning the cheap multiple partly reflects low returns on a large, leveraged asset base rather than pure mispricing. Revenue growth has stalled to +1.5% after the prior year's strong rebound, so the earnings gains are coming from operating leverage and credit normalization, not top-line momentum. The dividend is token (only $105M paid, a tiny fraction of $1.05B earnings), so this is a retained-capital story, not an income one.